Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction: Subanalysis from the DECLARE-TIMI 58 Trial. Have a read: https://www.m3india.in/contents/journal/dapagliflozin-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes?utm_campaign=unset&utm_medium=share&utm_source=ref_wa